INTRODUCTION
============

Osteoporosis, the most common bone disease,[@B1] is characterized by a progressive decrease in bone mass that leads to a decrease in bone strength and higher risk of fractures[@B1] and considered a public health problem responsible for the expenditure of R\$ 290 million from 2008 to 2010 by the Brazilian Unified Health System.[@B2] As the Brazilian population ages, the incidence of osteoporotic fractures (OF) is increasing. The number of proximal femoral fractures is estimated to increase from 80,640 in 2015 to 198,000 in 2040.[@B3]

In addition to the economic impact, OF have a great social cost since they are associated with an increased mortality rate, decreased independence,[@B4] loss of self-esteem, depression, and distortion of body image.[@B5] Although osteoporosis treatment has been available since the 1990s, up to 80% of eligible patients do not receive treatment.[@B6] This treatment failure is associated with the disastrous socioeconomic consequences of OF, especially proximal femoral fractures. This led to the development of secondary prevention programs[@B7] aiming at reducing the incidence of OF, especially proximal femoral fractures.

Although these programs are cost-effective[@B8] and capable of reducing mortality rates,[@B9] they have not been able to reduce the incidence of new proximal femoral fractures, which may be due to low treatment adherence.[@B10] ^,^ [@B11]

Unfortunately, studies on the epidemiology of patients with OF in Brazil are scarce, which makes it difficult to implement a program to reduce the impacts of osteoporosis.

This study aimed to evaluate the epidemiological profile of the population affected by OF (proximal femoral fractures, proximal humoral fractures, distal radial fractures, and thoracolumbar spinal fractures) treated in an orthopedic tertiary care hospital over a 12-month period with or without a previous diagnosis of osteopenia or osteoporosis and compare this profile with that of patients with osteoarthritis (OA) treated in the same period and identify factors that may decrease the adherence rates of OF patients to a secondary prevention program.

OBJECTIVES
==========

Primary objective
-----------------

The primary objective of this study was to describe the epidemiological profile of patients with OF treated in a tertiary orthopedic care hospital and identify the possible factors associated with this fracture compared to patients with OA treated during the same period.

### Secondary objective

The secondary objective of this study was to describe the characteristics associated with lower adherence rates to a secondary prevention program and the function of patients with OF.

MATERIALS AND METHODS
=====================

The Osteometabolic Diseases Group conducted this study upon receiving ethics committee approval (number 76629217.3/0000.0068). All patients signed an informed consent form after having their doubts clarified. The study included all patients admitted in the Orthopedic Institute for treatment of the OF in the period of twelve months and patients with knee OA (only those treated in the osteometabolic diseases group of a tertiary orthopedic care hospital).

Inclusion criteria: Study group (patients with OF): Patients \> 45 years of age who had one or more of the following fractures: proximal femur, proximal humerus, distal radius, and thoracolumbar spine. Patients with high-energy fractures were not included.

Control group (patients with OA): Patients \> 45 years of age with a clinical and radiographic diagnosis of knee OA isolated or not and with or without comorbidities.

Exclusion criteria: Patients \< 45 years of age with suspected or confirmed pathological fractures; non-collaborative patients.

Interventions: The participants answered a questionnaire ([Table 1](#t1){ref-type="table"}) that was used to collect data such as demographic profile, fracture type, ethnicity, education level, personal history, previous fractures, physical activity level, mobility, place and time of the accident that caused the fracture, use of medications and behavioral measures to treat osteoporosis, and evaluation of functionality according to Katz and Lawton & Brody (12,13). Following the international protocol, all patients in the OF group were referred to a secondary prevention outpatient clinic.[@B7]

###### Description of patient characteristics by group and results of the unadjusted analyses.

                                                  Group                                                               
  ----------------------------------------------- ------------- ------------- ------------- -------- ------- -------- -------------------------------------------
  Gender (female), n (%)                          68 (79.1)     78 (72.2)     146 (75.3)    0.69     0.35    1.34     0.272
  Age (years), mean SD                            65 ± 8.9      75.2 ± 11.1   70.7 ± 11.3   1.11     1.07    1.14     \<0.001[\*\*](#TFN3){ref-type="table-fn"}
  Weight (kg), mean SD                            73.7 ± 14.2   66.9 ± 13.7   69.9 ± 14.3   0.97     0.95    0.99     \<0.001[\*\*](#TFN3){ref-type="table-fn"}
  Height (cm), mean SD                            160.7 ± 7.3   160.7 ± 8.5   160.7 ± 8     1.00     0.96    1.04     0.971[\*\*](#TFN3){ref-type="table-fn"}
  BMI (kg/m^2^), mean SD                          28.5 ± 5      26 ± 5.3      27.1 ± 5.3    0.91     0.86    0.96     \<0.001[\*\*](#TFN3){ref-type="table-fn"}
  Education (literate), n (%)                     84 (97.7)     95 (88)       179 (92.3)    0.17     0.04    0.79     0.012
  Education (school years), median (min.; max.)   8 (0; 30)     8 (0; 18)     8 (0; 30)     0.96     0.91    1.02     0.160[£](#TFN4){ref-type="table-fn"}
  Ethnicity (Caucasian), n (%)                    60 (69.8)     94 (87)       154 (79.4)    2.91     1.41    6.01     0.003
  Civil status, n (%)                                                                                                 \<0.001
  Married                                         52 (60.5)     34 (31.5)     86 (44.3)     1.00                      
  Widower                                         11 (12.8)     42 (38.9)     53 (27.3)     5.84     2.64    12.90    
  Single                                          7 (8.1)       16 (14.8)     23 (11.9)     3.50     1.30    9.39     
  Other                                           16 (18.6)     16 (14.8)     32 (16.5)     1.53     0.68    3.46     
  Living with, median (min.; max.)                1 (0; 5)      1 (0; 6)      1 (0; 6)      0.97     0.77    1.23     0.454[£](#TFN4){ref-type="table-fn"}
  Father or mother with hip fx, n (%)             5 (5.8)       12 (11.1)     17 (8.8)      2.03     0.69    5.99     0.195
  Current smoker, n (%)                           9 (10.5)      18 (16.7)     27 (13.9)     1.71     0.73    4.03     0.215
  Glucocorticoid, n (%)                           4 (4.7)       8 (7.4)       12 (6.2)      1.64     0.48    5.64     0.429
  Secondary osteoporosis, n (%)                   8 (9.3)       6 (5.6)       14 (7.2)      0.57     0.19    1.72     0.316
  Alcohol use \>3 doses per day, n (%)            5 (5.8)       3 (2.8)       8 (4.1)       0.46     0.11    1.99     0.470[\*](#TFN2){ref-type="table-fn"}
  Sedatives, n (%)                                9 (10.5)      9 (8.3)       18 (9.3)      0.78     0.30    2.05     0.611
  Previous falls, n (%)                           16 (18.6)     56 (51.9)     72 (37.1)     4.71     2.43    9.13     \<0.001
  Cognitive impairment, n (%)                     3 (3.5)       15 (13.9)     18 (9.3)      4.46     1.25    15.96    0.013
  Visual impairment, n (%)                        38 (44.2)     55 (50.9)     93 (47.9)     1.31     0.74    2.32     0.351
  Lower limb impairment, n (%)                    15 (17.4)     10 (9.3)      25 (12.9)     0.48     0.21    1.14     0.091
  Foot pathologies, n (%)                         25 (29.1)     8 (7.4)       33 (17)       0.20     0.08    0.46     \<0.001
  Change in balance, n (%)                        25 (29.1)     33 (30.6)     58 (29.9)     1.07     0.58    2.00     0.822
  Muscle weakness, n (%)                          35 (40.7)     29 (26.9)     64 (33)       0.54     0.29    0.98     0.042
  Altered gait, n (%)                             24 (27.9)     29 (26.9)     53 (27,3)     0.95     0.50    1.79     0.870
  Postural hypotension, n (%)                     14 (16.3)     16 (14.8)     30 (15.5)     0.89     0.41    1.95     0.779
  Dizziness, n (%)                                20 (23.3)     24 (22.2)     44 (22.7)     0.94     0.48    1.85     0.864
  Depression/apathy/confusion, n (%)              13 (15.1)     22 (20.4)     35 (18)       1.44     0.68    3.05     0.344
  Diabetes, n (%)                                 27 (31.4)     35 (32.4)     62 (32)       1.05     0.57    1.93     0.881
  SAH, n (%)                                      52 (60.5)     56 (51.9)     108 (55.7)    0.70     0.40    1.25     0.230
  Hypothyroidism, n (%)                           19 (22.1)     15 (13.9)     34 (17.5)     0.57     0.27    1.20     0.135
  Previous fractures, n (%)                       15 (17.4)     48 (44.4)     63 (32.5)     3.79     1.93    7.43     \<0.001
  Old fracture (\>1 year), n (%)                  15 (17.4)     50 (46.3)     65 (33.5)     4.08     2.08    8.00     \<0.001
  Physical activity before fracture, n (%)        30 (34.9)     25 (23.1)     55 (28.4)     0.56     0.30    1.06     0.072
  Fear of falling, n (%)                          52 (60.5)     67 (62)       119 (61.3)    1.07     0.60    1.91     0.823
  Falls in the last 12 months, n (%)              18 (20.9)     58 (53.7)     76 (39.2)     4.38     2.31    8.33     \<0.001
  Fracture due to fall, n (%)                     2 (2.3)       104 (96.3)    106 (54.6)    1092.0   195.2   6107.8   \<0.001
  Help, n (%)                                     7 (8.1)       62 (57.4)     69 (35.6)     15.21    6.43    36.02    \<0.001
  Previous diagnosis of osteoporosis, n (%)       27 (31.4)     35 (32.4)     62 (32)       1.05     0.57    1.93     0.881
  Calcium use, n (%)                              30 (34.9)     26 (24.1)     56 (28.9)     0.59     0.32    1.11     0.099
  Sunbathe 3x week, n (%)                         49 (57)       56 (51.9)     105 (54.1)    0.81     0.46    1.44     0.477
  Vitamin D use, n (%)                            53 (61.6)     32 (29.6)     85 (43.8)     0.26     0.14    0.48     \<0.001
  Osteoporosis drug use, n (%)                    4 (4.7)       15 (13.9)     19 (9.8)      3.31     1.06    10.36    0.032
  Katz & Lawton DLA, median (min.; max.)          6 (3; 6)      6 (0; 6)      6 (0; 6)      0.49     0.29    0.82     \<0.001[£](#TFN4){ref-type="table-fn"}
  Katz & Lawton IADL, median (min.; max.)         8 (1; 8)      8 (0; 8)      8 (0; 8)      0.73     0.62    0.86     \<0.001[£](#TFN4){ref-type="table-fn"}

Chi-square test

Fisher\'s exact test

Student\'s t-test;

Mann-Whitney\'s U-test.

Statistical analysis
--------------------

We describe the characteristics of the patients using absolute and relative frequencies by groups for qualitative variables and verified the association using chi-square tests or Fisher\'s exact test. We calculated summary measurements (mean and standard deviation or median, minimum, and maximum) by groups for quantitative variables and compared the groups using Student\'s t-test or the Mann-Whitney U-test. In fractured patients, the characteristics were described according to adherence or loss of follow-up and the same tests were performed as previously described. The unadjusted odds ratio of each variable was used to estimate the chance of OF; in the fractured patients, the chance of loss of follow-up was determined with the respective intervals at a 95% confidence level. Multiple logistic regression models were estimated to explain the group of osteoporotic fractures; in the fractured patients, loss of follow-up, selecting the variables that were significant in the bivariate tests and using stepwise backward regression to select the variables with criteria for entry and exit of variables at 5% (p \< 0.05). SPSS for Windows version 20.0 was used to perform the analyses and the data were entered in Microsoft Excel 2003. The tests were performed using a significance level of 5%.

RESULTS
=======

The results of the questionnaires administered to 108 patients with OF and 86 patients with knee OA (or OA of multiple joints including the knee) are summarized in [Table 1](#t1){ref-type="table"}.

[Table 1](#t1){ref-type="table"} shows that, in isolation, the patients with OF were older (p \< 0.001) and had a lower mean weight and lower BMI (p \< 0.001). The frequency of literacy was lower (p = 0.012), the frequency of Caucasian race was higher (p = 0.003), and the frequency of married individuals was lower (p \< 0.001) in the OF group.

Patients with OF had more previous falls, cognitive impairment, previous fractures, old fracture (\>1 year), fall in the last 12 months, fracture after a fall, needed more help, and took more medication for osteoporosis (p \< 0.05). They had fewer foot pathologies, muscle weakness, took less vitamin D, and had lower Katz & Lawton\'s Activities of Daily Living (ADL) and Instrumental ADL (IADL) scores (p \< 0.001). [Table 2](#t2){ref-type="table"} shows that patient age, ethnicity, marital status, previous falls, foot pathologies, muscle weakness, previous fractures, use of vitamin D, use of medications for osteoporosis and Katz & Lawton\'s IADL explained the occurrence of OF in the patients regardless of the other evaluated characteristics (p \< 0.05). For each 1-year increase in patient age, the chance of OF increased 8%; Caucasian patients were 6.58 times more likely to have OF than non-Caucasian patients; those who were widowed or single or had another marital status were more likely to have OF than married patients; patients with previous falls were 8.15 times more likely to have OF than those without previous falls; patients with previous fractures were 4.55 times more likely to have OF than those without previous fractures; and patients who used medications for osteoporosis were 27.39 times more likely to have OF than those who did not. The factors that decreased the chance of OF were: foot pathologies (decreased the chance of OF by 91%); muscle weakness (decreased the chance of OF by 92%); use of vitamin D (decreased the chance of OF by 90%); and level of independence on the Katz & Lawton scale (decreased the chance of OF by 38% for each unit increase in scale score).

###### Results of the joint model to explain the fracture group by osteporosis according to evaluated characteristics.

  Variable                OR      CI (95%)   p        
  ----------------------- ------- ---------- -------- ---------
  Age (years)             1.08    1.03       1.13     0.002
  Ethnicity (caucasian)   6.58    1.71       25.00    0.006
  Civil status                                        
  Married                 1.00                        
  Widower                 4.27    1.22       15.02    0.024
  Single                  31.35   5.35       183.61   \<0.001
  Other                   6.41    1.50       27.38    0.012
  Previous fall           8.15    2.21       30.07    0.002
  Foot pathologies        0.09    0.02       0.42     0.002
  Muscle weakness         0.08    0.02       0.32     \<0.001
  Previous fracture       4.55    1.45       14.24    0.009
  Vitamin D use           0.10    0.03       0.31     \<0.001
  Osteoporosis drug use   27,39   3,00       249,99   0,003
  Katz & Lawton IADL      0,62    0,47       0,82     0,001

Multiple logistic regression.

[Table 3](#t3){ref-type="table"} shows that, in isolation, fractured patients who were lost to follow-up more frequently were older (p = 0.020), used more sedatives (p = 0.020), had more falls (p = 0.035), or had cognitive impairment (p = 0.044) or depression/apathy/confusion (p \<0.001). [Table 4](#t4){ref-type="table"} shows that, together, the chance of loss of follow-up increased 10% with each 1-year increase in patient age; the chance of follow-up loss in patients who used sedation was 8.69 times higher that of patients who did not; and the chance of follow-up loss in patients who had depression/apathy/confusion was 8.50 times higher than that chance of patients who did not have these symptoms.

###### Description of the characteristics of the fractured patients according to loss of follow-up and result of the unadjusted analyzes.

                                                 Attendance                                                              
  ---------------------------------------------- ------------- ------------- ------------- ---------- ------- ---------- -----------------------------------------
                                                 (N = 87)      (N = 14)      (N = 101)                Lower   Superior   
  Gender (female), n (%)                         63 (72.4)     11 (78.6)     74 (73.3)     0.88       0.36    2.11       0.754
  Age (years), mean SD                           73.8 ± 11     81.2 ± 10.2   74.8 ± 11.2   1.02       0.98    1.06       0.020[\*\*](#TFN8){ref-type="table-fn"}
  Weight (Kg), mean SD                           67.7 ± 13.6   64.1 ± 11.5   67.2 ± 13.4   0.98       0.94    1.02       0.344[\*\*](#TFN8){ref-type="table-fn"}
  Height (cm), mean SD                           160.3 ± 8.5   161.5 ± 8.6   160.4 ± 8.5   1.02       0.95    1.09       0.611[\*\*](#TFN8){ref-type="table-fn"}
  BMI (Kg/m^2^), mean SD                         26.5 ± 5.4    24.5 ± 3.5    26.2 ± 5.2    0.91       0.80    1.05       0.190[\*\*](#TFN8){ref-type="table-fn"}
  Education (literate), n (%)                    78 (89.7)     13 (92.9)     91 (90.1)     0.36       0.13    1.03       \>0.999
  Education (school years), median (min.;max.)   8 (0; 18)     8 (1; 15)     8 (0; 18)     1.01       0.90    1.13       0.653[£](#TFN9){ref-type="table-fn"}
  Ethnicity (Caucasian), n (%)                   76 (87.4)     11 (78.6)     87 (86.1)     0.81       0.26    2.54       0.406
  Civil status, n (%)                                                                                                    0.844\#
  Married                                        26 (29.9)     5 (35.7)      31 (30.7)     1.00                          
  Windower                                       34 (39.1)     6 (42.9)      40 (39.6)     0.70       0.26    1.88       
  Single                                         14 (16.1)     2 (14.3)      16 (15.8)     1.69       0.58    4.95       
  Orther                                         13 (14.9)     1 (7.1)       14 (13.9)     0.36       0.07    1.891      
  Living with, median (mín.; máx.)               1 (0; 6)      1 (0; 4)      1 (0; 6)      0.95       0.63    1.45       0.815[£](#TFN9){ref-type="table-fn"}
  Father ou mother with hi fx, n (%)             11 (12.6)     1 (7.1)       12 (11.9)     0.53       0.06    4.47       \>0.999
  Current somoker, n (%)                         17 (19.5)     1 (7.1)       18 (17.8)     0.32       0.04    2.59       0.454
  Glucocorticoid, n (%)                          6 (6.9)       2 (14.3)      8 (7.9)       2.25       0.41    12.46      0.306
  Secondary osteoporosis, n (%)                  5 (5.7)       0 (0)         5 (5)         &                             \>0.999
  Alcohol use \> 3 doses per day, n (%)          3 (3.4)       0 (0)         3 (3)         &                             \>0.999
  Sedatives, n (%)                               5 (5.7)       4 (28.6)      9 (8.9)       6.56       1.51    28.52      0.020
  Previous fall, n (%)                           42 (48.3)     11 (78.6)     53 (52.5)     3.93       1.02    15.07      0.035§
  Cognitive impairment, n (%)                    7 (8)         4 (28.6)      11 (10.9)     4.57       1.14    18.41      0.044
  Visual impairment, n (%)                       46 (52.9)     6 (42.9)      52 (51.5)     0.67       0.21    2.09       0.486§
  Lower limb impairment, n (%)                   8 (9.2)       2 (14.3)      10 (9.9)      1.65       0.31    8.69       0.626
  Foot pathologies, n (%)                        6 (6.9)       2 (14.3)      8 (7.9)       2.25       0.41    12.46      0.306
  Change in balance, n (%)                       25 (28.7)     7 (50)        32 (31.7)     2.48       0.79    7.80       0.130
  Muscle weakness, n (%)                         20 (23)       6 (42.9)      26 (25.7)     2.51       0.78    8.10       0.184
  Altered gait, n (%)                            21 (24.1)     6 (42.9)      27 (26.7)     2.36       0.73    7.57       0.192
  Postural hypotension, n (%)                    12 (13.8)     2 (14.3)      14 (13.9)     1.04       0.21    5.24       \>0.999
  Dizziness, n (%)                               17 (19.5)     5 (35.7)      22 (21.8)     2.29       0.68    7.71       0.179
  Depression/apathy/confusion, n (%)             13 (14.9)     9 (64.3)      22 (21.8)     10.25      2.96    35.48      \<0.001
  Diabetes, n (%)                                28 (32.2)     6 (42.9)      34 (33.7)     1.58       0.50    4.99       0.544
  SAH, n (%)                                     45 (51.7)     9 (64.3)      54 (53.5)     1.68       0.52    5.42       0.382§
  Hypothyroidism, n (%)                          11 (12.6)     3 (21.4)      14 (13.9)     1.88       0.45    7.83       0.406
  Previous fractures, n (%)                      38 (43.7)     8 (57.1)      46 (45.5)     1.72       0.55    5.38       0.348§
  Old fracture (\> 1 year), n (%)                40 (46)       8 (57.1)      48 (47.5)     1.57       0.50    4.90       0.437§
  Physical activity before fracture, n (%)       24 (27.6)     1 (7.1)       25 (24.8)     0.20       0.03    1.63       0.179
  Fear of falling, n (%)                         54 (62.1)     10 (71.4)     64 (63.4)     1.53       0.44    5.27       0.500§
  Falls int he last 12 months, n (%)             46 (52.9)     8 (57.1)      54 (53.5)     1.19       0.38    3.71       0.766§
  Fracture due to fall, n (%)                    84 (96.6)     14 (100)      98 (97)       &                             \>0.999
  Help, n (%)                                    49 (56.3)     9 (64.3)      58 (57.4)     1.40       0.43    4.51       0.576§
  Previous diagnosis of osteoporosis, n (%)      29 (33.3)     4 (28.6)      33 (32.7)     0.80       0.23    2.77       \>0.999
  Calcium use, n (%)                             22 (25.3)     3 (21.4)      25 (24.8)     0.81       0.21    3.16       \>0.999
  Sunbathe 3x week, n (%)                        46 (52.9)     7 (50)        53 (52.5)     0.89       0.29    2.76       0.842§
  Vitamin D use, n (%)                           28 (32.2)     3 (21.4)      31 (30.7)     0.58       0.15    2.23       0.541
  Osteoporosis drug use, n (%)                   15 (17.2)     0 (0)         15 (14.9)     &                             0.121
  Katz & Lawton DLA, median (mín.; máx.)         6 (0; 6)      6             (3; 6)        6 (0; 6)   0.91    0.591.40   0.224[£](#TFN9){ref-type="table-fn"}
  Katz & Lawton IADL, median (mín.; máx.)        8 (0; 8)      5 (0; 8)      8 (0; 8)      0.86       0.70    1.06       0.245[£](#TFN9){ref-type="table-fn"}

Chi-square test;

Fisher\'s exact test;

Student\'s t-test;

Mann-Whitney\'s U-test.

###### Results of the joint model to explain follow-up loss of fracture patients according to evaluated characteristics.

  Variável                      OR     CI (95%)   p       
  ----------------------------- ------ ---------- ------- -------
  Age (years)                   1.10   1.02       1.19    0.012
  Sedative use                  8.69   1.36       55.45   0.022
  Depression/apathy/confusion   8.50   2.19       33.09   0.002

Multiple logistic regression

DISCUSSION
==========

We found that patients with OF were older, weighed less, had a lower mean BMI, and were more likely to be Caucasian, findings that are in agreement with the results of other studies.[@B14] ^,^ [@B15] However, no great influence of glucocorticoid consumption, alcohol consumption, or smoking was observed as described in the literature.[@B14] We found a protective relationship against OF in married patients compared to those with other marital statuses ([Table 1](#t1){ref-type="table"}) as in our previous studies.[@B15]

Patients with osteoporosis had more previous falls, a greater number of falls in the last year associated with bone fragility, old fractures (\>1 year), and more previous fractures. The OF group used more medication for the treatment of osteoporosis, needed more help, and had lower Katz & Lawton\'s ADL and IADL scores. The greater number of falls can be explained by higher age and eventual sarcopenia,[@B16] ^,^ [@B17] and possible sequelae of previous fractures due to pain and changes in alignment reducing the frequency of physical activity, which leads to decreased bone and muscle mass, which predisposes patients to further falls and fractures.[@B18]

Patients with OF had fewer foot pathologies and muscle weakness and took less vitamin D. We believe that this is a bias since the patients in the OA group are currently in outpatient follow-up associated with a holistic multiprofessional educational program for the treatment of OA,[@B19] which enables these patients to recognize deformities, pathologies, and muscle weaknesses. Moreover, they are actively studied for vitamin D deficiency. It is worth mentioning that muscle weakness was self-reported; we did not perform functional objective tests.

Approximately 14% of patients with OF refused to participate in the secondary prevention program. The variables identified as risk factors for follow-up loss were age, use of sedatives, cognitive deficit, greater number of falls, and presence of depression/apathy/confusion. The greatest number of falls may be associated with the use of sedatives and cognitive disorder, although we cannot confirm this with our data. Using multiple logistic regression, we found that: the chance of follow-up loss increased 10% with each 1-year increase in patient age; the use of sedatives increased the chance of follow-up loss by 8.69 times; symptoms of depression/apathy/confusion increased the chance of follow-up loss by 8.5 times.

To improve adherence to the secondary prevention program of this subgroup, patients and their families may need an intensive educational program[@B20] that has already reduced falls, increased the frequency of physical activity, improved adherence to drug treatment, and increased the overall quality of life in patients with osteoporosis.

CONCLUSION
==========

Together, patient age, ethnicity, marital status, previous falls, foot pathologies, muscle weakness, previous fractures, use of vitamin D, use of osteoporosis drugs, and Katz & Lawton IADL scale score define patients with OF. The risk factors for non-adherence to the secondary prevention program are patient age, sedative use, cognitive disorder, and the presence of depression/apathy/confusion.
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